Finzati - Logo
CURX logo

Curanex Pharmaceuticals Inc Common Stock

CURX • Biotechnology
$5.05
▲ +0.31 (+6.54%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 62%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$143.24M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.03Healthy liquidity · 81.93Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:19 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$5.05
Change6.54%
Shares Out28.36M
Market Cap$143.24M
Enterprise Value$140.58M
52W Range0.18 - 9.18
Beta-2.74
P/E-13.68
P/B29.92
P/FCF-11.86
EV/EBITDA-13.33
EV/FCF-11.64

Investment DNA

How strong this company looks for long-term investors

50
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.03Healthy liquidity · 81.93Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 8/26/2025
Industry: Biotechnology
P/B i: 29.92
Debt / Equity i: 0.03
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.03
Current Ratio: 81.93
Quick Ratio: 81.93
Status: Strong

Insider Transactions

Recent executive and insider activity

Jing Dian Ying
Transaction: 08/25/2025
OTHER
Change
0
Price
Not reported
Filing
09/02/2025
Type
OTHER
Jing Dian Ying
Transaction: 08/25/2025
OTHER
Change
0
Price
Not reported
Filing
09/02/2025
Type
OTHER
Liu Chang
Transaction: 08/25/2025
OTHER
Change
0
Price
Not reported
Filing
09/02/2025
Type
OTHER